Pancreatic ? cells function as glucose sensors and control GSIS. Insulin from pancreatic ? cells inhibits gluconeogenesis and induces glycogen synthesis in the liver, which is the important organ in controlling blood glucose. Beta cells (? cells) are a type of cell found in pancreatic islets that synthesize and secrete insulin and amylin. Beta cells make up 50?70% of the cells in human islets. In patients with type I or type II diabetes, beta-cell mass and function are diminished, leading to insufficient insulin secretion and hyperglycemia.
MARKET DYNAMICS
The pancreatic beta-cell protection market is driving due to the growing prevalence of chronic diseases and rising diabetic patients. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research boost the market growth in the forecast period.
MARKET SCOPE
The "Pancreatic Beta-Cell Protection Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pancreatic beta-cell protection market with detailed market segmentation by product and application. The pancreatic beta-cell protection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pancreatic beta-cell protection market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pancreatic beta-cell protection market is segmented on the basis of product and application. Based on product, the market is segmented as stem cell based, gene therapies, RNA based therapies, monoclonal antibodies (mabs) and phytotherapy. On the basis of application, the market is categorized as hospital, medical research laboratory and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pancreatic beta-cell protection market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pancreatic beta-cell protection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pancreatic beta-cell protection market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pancreatic beta-cell protection market in these regions.
MARKET PLAYERS
The report covers key developments in the pancreatic beta-cell protection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pancreatic beta-cell protection market are anticipated to have lucrative growth opportunities in the future with the rising demand for pancreatic beta-cell protection in the global market. Below mentioned is the list of few companies engaged in the pancreatic beta-cell protection market.
The report also includes the profiles of key players in pancreatic beta-cell protection market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Beta-Cell NV
- Beta-O2 Technologies Ltd
- BioLineRx
- Boehringer Ingelheim
- GalaxoSmithKline
- Genentech
- Janssen Research and Development
- Novartis
- Novo Nordisk
- Pfizer Inc
- Sanofi
- Transition Therapeutics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.